CuraGen pulls the trigger

Add CuraGen Corp. to the list of well-capitalized companies that are proactively trimming workforces and spending to make the best use of their resources in a bear market. With $431 million in cash that it wants to last four years, CRGN is accelerating the transition of its workforce from a discovery orientation to product

Read the full 543 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers